Scrotal Cutaneous Side Effects of Sunitinib
Scrotal Cutaneous Side Effects of Sunitinib
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Sunitinib was approved in 2006 for the treatment of advanced renal-cell carcinoma and gastrointestinal stromal tumors. These authors report on patients who had dermatologic toxic effects in both the scrotal and inguinal areas.
To the Editor:
Sunitinib is an oral, multitargeted kinase that blocks the receptors for vascular endothelial growth f...
Alternative Titles
Full title
Scrotal Cutaneous Side Effects of Sunitinib
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_223920036
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_223920036
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc0802736
